A Look At E.l.f. Beauty (ELF) Valuation After Strong Results Analyst Caution And Rhode Expansion

e.l.f. Beauty (ELF) is in the spotlight after a busy stretch that combined stronger-than-expected quarterly results, cautious analyst commentary on demand, insider stock sales, and a fresh global expansion push for Rhode.

See our latest analysis for e.l.f. Beauty.

The recent 1-day share price return of 4.40% and 7-day share price return of 11.79% come after a tougher stretch, with the 90-day share price return down 19.92% and the 1-year total shareholder return down 53.32%. The 5-year total shareholder return remains positive at 106.61%, suggesting near term sentiment has softened even as longer term holders are still in the green.

If e.l.f. Beauty’s volatility has you thinking about diversification, this could be a good moment to scan the market and uncover 20 top founder-led companies

With revenue and net income still growing, a share price that has fallen sharply over 1 and 3 years, and analyst targets sitting above the current price, you have to ask: is this weakness a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 19.7% Undervalued

e.l.f. Beauty's most followed narrative pegs fair value at $72.40, above the last close at $58.12. This puts a spotlight on what is driving that gap.

The expansion into new international markets and rapid growth in existing ones (e.g., 30% international net sales growth, top rankings in new geographies, global Sephora rollout) provides significant runway for future revenue growth and increased diversification, which is likely under-appreciated by the market.

Read the complete narrative.

Curious what sits behind that optimism? The fair value hinges on a blend of mid single digit revenue assumptions, a sharp earnings ramp, and a richer future earnings multiple. The tension lies in how those three pieces fit together and what needs to go right for the narrative to hold.

Result: Fair Value of $72.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this narrative can weaken if tariff related cost pressure persists or if slower core cosmetics volumes limit what Rhode and skincare can realistically offset.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another Angle On Valuation

The popular narrative leans on earnings growth and a richer future P/E, but the current P/E of 131.3x is far above both the peer average of 10.5x and the fair ratio of 22.3x. That gap points to meaningful valuation risk if sentiment or growth expectations cool from here.

Before you lean too heavily on any single story, it is worth asking what would need to change in the business or the share price for that P/E to move closer to the fair ratio, and how comfortable you are with that adjustment path.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals on valuation and sentiment, it makes sense to move fast, look through the full picture yourself, and weigh both sides of the story. Before you settle on an opinion, take a moment to review the 1 key reward and 4 important warning signs

Looking for more investment ideas?

If you are reassessing e.l.f. Beauty, this is a smart time to widen your watchlist and let data rich screeners surface fresh opportunities for you.

• Target potential bargains by scanning companies that combine quality, valuation and fundamentals through the 48 high quality undervalued stocks
• Prioritize financial resilience by focusing on businesses highlighted in the solid balance sheet and fundamentals stocks screener (46 results)
• Get ahead of the crowd by reviewing a screener containing 20 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com